Latest news
OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision - StocktwitsStocktwits · Sat, 08 Aug 2026 07:13:33 GMTOTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal - StocktwitsStocktwits · Fri, 07 Aug 2026 22:28:56 GMTOTLK Stock Rocket Nearly 140%: FDA's Lytenava FDR Approval Pushes Stock On Track For Best Week On Record - StocktwitsStocktwits · Fri, 07 Aug 2026 01:43:58 GMTOutlook Therapeutics Stock (OTLK) Opinions on FDA Approval of LYTENAVA - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 14:05:00 GMTRetina specialists weigh in on FDA approval of bevacizumab-vikg (Lytenava) for wet AMD - Ophthalmology Times EuropeOphthalmology Times Europe · Sun, 02 Aug 2026 19:01:11 GMTOutlook: 'Hold' - Caution On LYTENAVA FDA Approval And Cash Needs (NASDAQ:OTLK) - Seeking AlphaSeeking Alpha · Tue, 28 Jul 2026 07:00:00 GMTOutlook Therapeutics wins FDA nod for Lytenava in neovascular AMD - Indian Pharma PostIndian Pharma Post · Tue, 28 Jul 2026 06:33:45 GMTFDA approves Outlook's LYTENAVA for wet AMD - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Mon, 27 Jul 2026 18:59:58 GMT